Perkins Coie Trust »

Crispr Therapeutics shares owned by Perkins Coie Trust

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Perkins Coie Trust from 13F filings

Historical chart of Perkins Coie Trust investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Perkins Coie Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Perkins Coie Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 200 68.15
2023-12-31 $13k 200 62.60

More positions owned by Perkins Coie Trust

Vanguard Mid Cap Etf Equity - Midcap - Etf (VO)
Vanguard Ftse Developed Mkts Index Etf Equity - International - Etf (VEA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Vanguard Russell 1000 Growth Etf Equity - Large Cap - Etf (VONG)
Ishares S&p 500 Growth Etf Equity - Large Cap - Etf (IVW)
Alphabet Inc Cl A Common Stock (GOOGL)
Eaton Corp Foreign Equities (ETN)
Boeing Common Stock (BA)
Qualcomm Common Stock (QCOM)
Visa Common Stock (V)
Vanguard Mid Cap Etf Equity - Midcap - Etf
Home Depot Common Stock (HD)
Amazon.com Common Stock (AMZN)
Procter & Gamble Common Stock (PG)

View all positions for Perkins Coie Trust

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics